199 related articles for article (PubMed ID: 28283002)
1. Losing a foot versus losing a dollar; a systematic review of cost studies in diabetic foot complications.
Petrakis I; Kyriopoulos IJ; Ginis A; Athanasakis K
Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):165-180. PubMed ID: 28283002
[TBL] [Abstract][Full Text] [Related]
2. Annual Direct Medical Costs of Diabetic Foot Disease in Brazil: A Cost of Illness Study.
Toscano CM; Sugita TH; Rosa MQM; Pedrosa HC; Rosa RDS; Bahia LR
Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29316689
[TBL] [Abstract][Full Text] [Related]
3. Health-economic consequences of diabetic foot lesions.
Ragnarson Tennvall G; Apelqvist J
Clin Infect Dis; 2004 Aug; 39 Suppl 2():S132-9. PubMed ID: 15306992
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of medical intervention in patients with early detection of diabetic foot in a tertiary care hospital in Bangladesh.
Habib SH; Biswas KB; Akter S; Saha S; Ali L
J Diabetes Complications; 2010; 24(4):259-64. PubMed ID: 19231246
[TBL] [Abstract][Full Text] [Related]
5. The cost of diabetic foot ulcers and amputations to the National Health Service in England.
Kerr M; Barron E; Chadwick P; Evans T; Kong WM; Rayman G; Sutton-Smith M; Todd G; Young B; Jeffcoate WJ
Diabet Med; 2019 Aug; 36(8):995-1002. PubMed ID: 31004370
[TBL] [Abstract][Full Text] [Related]
6. Burden of diabetic foot disorders, guidelines for management and disparities in implementation in Europe: a systematic literature review.
van Acker K; Léger P; Hartemann A; Chawla A; Siddiqui MK
Diabetes Metab Res Rev; 2014 Nov; 30(8):635-45. PubMed ID: 24470359
[TBL] [Abstract][Full Text] [Related]
7. Cost of diabetic foot disease to the National Health Service in England.
Kerr M; Rayman G; Jeffcoate WJ
Diabet Med; 2014 Dec; 31(12):1498-504. PubMed ID: 24984759
[TBL] [Abstract][Full Text] [Related]
8. Geographic variation in Medicare spending and mortality for diabetic patients with foot ulcers and amputations.
Sargen MR; Hoffstad O; Margolis DJ
J Diabetes Complications; 2013; 27(2):128-33. PubMed ID: 23062327
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary clinics reduce treatment costs and improve patient outcomes in diabetic foot disease.
Joret MO; Osman K; Dean A; Cao C; van der Werf B; Bhamidipaty V
J Vasc Surg; 2019 Sep; 70(3):806-814. PubMed ID: 30850290
[TBL] [Abstract][Full Text] [Related]
10. The Neuro-Vascular Consequence of Diabetes: Foot Amputation and Evaluation of its Risk Factors and Health-Related Economic Impact.
Naqvi IH; Talib A; Naqvi SH; Yasin L; Rizvi NZ
Curr Vasc Pharmacol; 2021; 19(1):102-109. PubMed ID: 32196452
[TBL] [Abstract][Full Text] [Related]
11. [Cost of the diabetic foot].
Halimi S; Benhamou PY; Charras H
Diabete Metab; 1993 Dec; 19(5 Suppl):518-22. PubMed ID: 8206191
[TBL] [Abstract][Full Text] [Related]
12. The economic burden of diabetic foot and ankle disorders.
Saar WE; Lee TH; Berlet GC
Foot Ankle Int; 2005 Jan; 26(1):27-31. PubMed ID: 15680115
[TBL] [Abstract][Full Text] [Related]
13. The costs of diabetic foot: the economic case for the limb salvage team.
Driver VR; Fabbi M; Lavery LA; Gibbons G
J Vasc Surg; 2010 Sep; 52(3 Suppl):17S-22S. PubMed ID: 20804928
[TBL] [Abstract][Full Text] [Related]
14. A Diabetic Emergency One Million Feet Long: Disparities and Burdens of Illness among Diabetic Foot Ulcer Cases within Emergency Departments in the United States, 2006-2010.
Skrepnek GH; Mills JL; Armstrong DG
PLoS One; 2015; 10(8):e0134914. PubMed ID: 26248037
[TBL] [Abstract][Full Text] [Related]
15. Reducing lower leg amputations in diabetes: a challenge for patients, healthcare providers and the healthcare system.
Schaper NC; Apelqvist J; Bakker K
Diabetologia; 2012 Jul; 55(7):1869-72. PubMed ID: 22622617
[TBL] [Abstract][Full Text] [Related]
16. The financial burden of surgical and endovascular treatment of diabetic foot wounds.
Joret MO; Dean A; Cao C; Stewart J; Bhamidipaty V
J Vasc Surg; 2016 Sep; 64(3):648-55. PubMed ID: 27565588
[TBL] [Abstract][Full Text] [Related]
17. [In hospital care for diabetic foot: a comparison between the estimated cost and the SUS reimbursement].
Rezende KF; Nunes MA; Melo NH; Malerbi D; Chacra AR; Ferraz MB
Arq Bras Endocrinol Metabol; 2008 Apr; 52(3):523-30. PubMed ID: 18506278
[TBL] [Abstract][Full Text] [Related]
18. Assessment of healthcare costs of amputation and prosthesis for upper and lower extremities in a Qatari healthcare institution: a retrospective cohort study.
Al-Thani H; Sathian B; El-Menyar A
BMJ Open; 2019 Jan; 9(1):e024963. PubMed ID: 30782746
[TBL] [Abstract][Full Text] [Related]
19. Technology-enabled remote management of diabetes foot disease and potential for reduction in associated health costs: a pilot study.
Main F; Zubala A; Gorman J; Jones S; Hall J; Macfarlane D; MacRury S
J Foot Ankle Res; 2021 Jan; 14(1):7. PubMed ID: 33436028
[TBL] [Abstract][Full Text] [Related]
20. Wound healing in diabetes. Outcome and costs.
Apelqvist J
Clin Podiatr Med Surg; 1998 Jan; 15(1):21-39. PubMed ID: 9463766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]